Clinical Trial Update: Follow-up Study to Evaluate the Safety and Efficacy of FCN-159 in Pediatric Participants With Neurofibromatosis Type 1 [Phase 1, Phase 2]

View source ↗

Summary

A registry update describing a Phase 1/Phase 2 follow-up study evaluating FCN-159 in pediatric patients with Neurofibromatosis Type 1, focusing on safety and ef…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Plexiform Neurofibroma

Drugs mentioned

• FCN-159

Snippet

Sponsor: Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | Conditions: Neurofibromatosis 1, Plexiform Neurofibroma | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING